MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 276 filers reported holding MYRIAD GENETICS INC in Q4 2014. The put-call ratio across all filers is 2.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $595,000 | -68.4% | 28,901 | -53.0% | 0.01% | -62.5% |
| Q2 2016 | $1,882,000 | -47.7% | 61,501 | -35.9% | 0.03% | -8.6% |
| Q3 2015 | $3,597,000 | +457.7% | 95,985 | +405.6% | 0.04% | +483.3% |
| Q2 2015 | $645,000 | -75.1% | 18,985 | -74.0% | 0.01% | -76.9% |
| Q1 2015 | $2,589,000 | +5.9% | 73,140 | +2.0% | 0.03% | +73.3% |
| Q4 2014 | $2,444,000 | -31.9% | 71,736 | -22.9% | 0.02% | -11.8% |
| Q3 2014 | $3,587,000 | -33.3% | 93,000 | -32.7% | 0.02% | -34.6% |
| Q2 2014 | $5,375,000 | -50.5% | 138,100 | -56.5% | 0.03% | -56.7% |
| Q1 2014 | $10,848,000 | +24.1% | 317,300 | -23.9% | 0.06% | +27.7% |
| Q4 2013 | $8,744,000 | -54.0% | 416,776 | -48.5% | 0.05% | -60.2% |
| Q3 2013 | $19,010,000 | +73.2% | 808,937 | +98.0% | 0.12% | +78.8% |
| Q2 2013 | $10,976,000 | – | 408,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |